Hydroxychloroquine with or Without Azithromycin for Treatment of Early SARS-CoV-2 Infection Among High-Risk Outpatient Adults: A Randomized Clinical Trial

Christine Johnston(University of Washington), Jared M. Baeten(University of Washington), Arun Raghav Mahankali Sridhar(University of Washington), Helen C. Stankiewicz Karita(University of Washington), Keith R. Jerome(University of Washington), Meei‐Li Huang(Infectious Disease Research Institute), Susan Morrison, Ruanne V. Barnabas(Harvard University), Sybil Hosek(University of Illinois Chicago), Hannah Leingang(University of Washington), Harald S. Haugen, Peter A. Noseworthy(Mayo Clinic in Arizona), Patricia Kissinger(Tulane University), Michael K. Paasche‐Orlow(Tufts Medical Center), Anna Wald(University of Washington), Temitope Oyedele(AstraZeneca (South Korea)), Michael J. Ackerman(Mayo Clinic), Jeanne E. Poole(Heart Rhythm Society), Mark H. Wener(University of Washington), Alexander L. Greninger(University of Washington), Kristopher Paolino(Walter Reed National Military Medical Center), Kate B. Heller(University of Washington), Joshua T. Schiffer(University of Washington), John Dwyer, Connie Celum(University of Washington), Elizabeth R. Brown(Fred Hutch Cancer Center), Anna Bershtyn(New York University), Helen Y. Chu(Seattle Pacific University), Tracy Qi Dong(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Jenell Stewart(Hennepin Healthcare Research Institute)
SSRN Electronic Journal
January 1, 2020
Cited by 11


Related Papers